Aging, AMP Kinase and Skeletal Muscle Overload
Aging, AMP Kinase and Skeletal Muscle Overload
批准号:
6954439
负责人:
SCOTT E GORDON
金额:
$19.24万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-09-01 至 2009-08-31
中文摘要
描述(由申请人提供):严重的骨骼肌萎缩导致功能独立性和生活质量的丧失,并且诸如阻力运动训练等干预措施在恢复老年人的肌肉质量方面并不完全有效。骨骼肌相关的萎缩,以及超负荷诱导的肥大能力的降低,主要发生在衰老骨骼肌的快缩纤维中。静息骨骼肌蛋白质合成率和翻译效率随年龄增长而下降,我们有强有力的数据表明,在静息和过载的大鼠骨骼肌中,5 '-AMP活化蛋白激酶(AMPK;抑制蛋白质翻译和合成)的磷酸化以快收缩特异性方式随年龄增长而上调。此外,AMPK磷酸化与超负荷诱导的快缩肌肥大程度呈紧密负相关。本研究的第一个目的是确定AMPK活性升高是否是老年动物静息快缩骨骼肌蛋白质合成速率随年龄增长而下降的原因。年轻成人(YA; 8个月),中年(MA; 19个月),和老年人(O; 30个月)对雄性Fisher 344 × BrownNorway大鼠单次注射盐水或AMPK激活剂AICAR(5-氨基咪唑-4-甲酰胺-1-β-D-呋喃核糖苷)。在快速收缩跖肌(PLT)肌肉中,将测量AMPK磷酸化/活性、混合蛋白和肌原纤维蛋白合成速率(通过3 H-苯丙氨酸掺入)、影响AMPK活性的AMPK-γ亚基和控制AMPK下游蛋白翻译的潜在信号传导中间体。我们假设AlCAR刺激的AMPK-Q2活性将抑制年轻成年和中年动物快缩跖肌的静息混合和肌原纤维蛋白合成速率,使其达到老年盐水处理动物的水平。本研究的第二个目的是确定AMPK活性升高是否与老龄动物超负荷快缩骨骼肌蛋白质合成速率的年龄相关性下降和肥大能力的年龄相关性下降有关。YA、MA和O雄性FBN大鼠将经历腓肠肌的单侧手术消融以使快缩PLT肌肉长期超负荷7天,在此期间将长期施用AICAR或盐水。7天后,将在PLT中再次测量AMPK磷酸化/活性、混合蛋白和肌原纤维蛋白合成速率、肥大、AMPK-γ亚基和信号传导中间体。我们假设AlCAR刺激的AMPK-a2活性将抑制YA和MA动物的超负荷快缩PLT肌肉中的静息混合蛋白和肌原纤维蛋白合成速率和肥大至在O盐水处理的动物中观察到的水平。这项研究的长期目标是阐明衰老快缩骨骼肌萎缩和受损肥大的机制,为本科生和研究生提供研究机会,并提供数据,以建立未来的R 01资助申请。
英文摘要
DESCRIPTION (provided by applicant): Significant skeletal muscle atrophy results in a loss of functional independence and quality of life, and interventions such as resistance exercise training are not fully effective in restoring muscle mass in elderly individuals. Age-related atrophy, as well as the diminished capacity for overload-induced hypertrophy, occur predominantly in fast-twitch fibers in aging skeletal muscle. Resting skeletal muscle protein synthesis rate and translational efficiency decline with age, and we have strong data showing that the phosphorylation of 5'-AMP- activated protein kinase (AMPK; which suppresses protein translation and synthesis) is upregulated with age in a fast-twitch-specific manner in resting and overloaded rat skeletal muscle. Moreover, AMPK phosphorylation was tightly and negatively correlated with the degree of overload-induced hypertrophy in fast-twitch muscles. The first aim of this investigation is to determine if elevated AMPK activity is responsible for the age-related decline in protein synthesis rate in resting fast-twitch skeletal muscles of old animals. Young adult (YA; 8 mo.), middle- aged (MA; 19 mo.), and old (O; 30 mo.) male Fisher 344 x Brown Norway rats will be given a single injection of saline or the AMPK activator AICAR (5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside). In fast-twitch plantaris (PLT) muscles, AMPK phosphorylation/activity, rates of mixed and myofibrillar protein synthesis (via 3H- phenylalanine incorporation), AMPK-y subunits influencing AMPK activity, and potential signaling intermediates controlling protein translation downstream of AMPK will be measured. We hypothesize that AlCAR-stimulated AMPK-Q2 activity will suppress resting mixed and myofibrillar protein synthesis rates in fast-twitch plantaris muscles of young adult and middle-aged animals to the levels seen in old saline-treated animals. The second aim of this investigation is to determine if elevated AMPK activity is responsible for an age-related decline in protein synthesis rate and the age-related decline in hypertrophic capacity in overloaded fast-twitch skeletal muscles of old animals. YA, MA, and O male FBN rats will undergo unilateral surgical ablation of the gastrocnemius to chronically overload the fast-twitch PLT muscle for 7 days, during which AICAR or saline will be chronically administered. After 7 days, AMPK phosphorylation/activity, rates of mixed and myofibrillar protein synthesis, hypertrophy, AMPK-y subunits, and signaling intermediates will again be measured in the PLT. We hypothesize that AlCAR-stimulated AMPK-a2 activity will suppress resting mixed and myofibrillar protein synthesis rates and hypertrophy in overloaded fast-twitch PLT muscles of YA and MA animals to levels seen in O saline-treated animals. The long-term objectives of this investigation are to elucidate mechanisms underlying the atrophy and impaired hypertrophy of aging fast-twitch skeletal muscle, to provide research opportunities for undergraduate and graduate students, and to provide data on which to establish future R01 grant applications.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1097/jes.0b013e3181877e13
发表时间:
2008-10
期刊:
Exercise and sport sciences reviews
影响因子:
5.7
作者:
[Gordon SE, Lake JA, Westerkamp CM, Thomson DM]
通讯作者:
Thomson DM
DOI:
10.1152/japplphysiol.00915.2007
发表时间:
2008-03
期刊:
Journal of applied physiology
影响因子:
3.3
作者:
[D. Thomson;C. A. Fick;S. Gordon]
通讯作者:
D. Thomson;C. A. Fick;S. Gordon
ROLE OF ANGIOTENSIN II IN SKELETAL MUSCLE HYPERTROPHY
-
批准号:6403161
-
项目类别:
-
资助金额:$1.32万
-
财政年份:2001
-
负责人:SCOTT E GORDON
-
依托单位:
ROLE OF ANGIOTENSIN II IN SKELETAL MUSCLE HYPERTROPHY
-
批准号:6062450
-
项目类别:
-
资助金额:$3.75万
-
财政年份:2000
-
负责人:SCOTT E GORDON
-
依托单位:
国内基金
海外基金
登录
查看更多内容
HIF-1α调控软骨细胞衰老在骨关节炎进展中的作用及机制研究
-
批准号:82371603
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:陈晓
-
依托单位:
间皮细胞衰老在腹膜透析后腹膜适应不良修复和纤维化发病中的作用及机制研究
-
批准号:82370743
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:姜娜
-
依托单位:
衰老抑制脊髓损伤修复的CXCL13依赖性CD8+T细胞通讯机制研究
-
批准号:82371585
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:周鲁明
-
依托单位:
衰老上皮细胞FABP4调控HSDL2致脂肪酸代谢失衡在BPH发病中的机制研究
-
批准号:82370774
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:阮渊
-
依托单位:
LMNA基因R527C纯合突变儿童早老症干细胞功能异常及分子机理研究
-
批准号:32100603
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:周焱
-
依托单位:
SIRT2在灵长类心肌衰老进程中的作用及其机制研究
-
批准号:32000510
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:范艳玲
-
依托单位:
NRF2/MFN2/ERS信号异常促进ADSCs衰老和肥大型肥胖皮下脂肪组织胰岛素抵抗的机制研究
-
批准号:32000511
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:方佳
-
依托单位:
隐性遗传方式儿童早老症患者SASP-like炎症反应病理特征和分子机制研究
-
批准号:32060157
-
项目类别:地区科学基金项目
-
资助金额:36.0万元
-
批准年份:2020
-
负责人:舒伟
-
依托单位:
c-Fos在皮肤上皮干细胞衰老中的作用研究
-
批准号:32070730
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2020
-
负责人:张亮
-
依托单位:
SETD8介导H4K20单甲基化修饰对MSCs抗衰老的作用机制
-
批准号:32060156
-
项目类别:地区科学基金项目
-
资助金额:36.0万元
-
批准年份:2020
-
负责人:刘鹏霞
-
依托单位: